Publications

TitlePrevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa
AuthorsCenter for Global Health & Development
PublicationInfectious Agents and Cancer. 2011 Nov; 6(22):8.
Abstract

Overview

Kaposi sarcoma (KS) is the most common AIDS-defining tumour in HIV-infected individuals in Africa.  Kaposi sarcoma herpes virus (KSHV) infection precedes development of KS.  KSHV co-infection may be associated with worse outcomes in HIV disease and elevated KSHV viral load may be an early marker for advanced HIV disease among untreated patients. We examined the prevalence of KSHV among adults initiating antiretroviral therapy (ART) and compared immunological, demographic and clinical factors between patients seropositive and seronegative for KSHV.
Full TextDownload Document
Related ProjectsEpidemiologic Analyses and HIV Treatment Outcomes in South Africa